Ligand validation:1DV6

U10: UBIQUINONE-10

U10 is a Ligand Of Interest in 1DV6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1DV6_U10_S_2008	34%	31%	0.17	0.94	1.75	1.11	5	4	0	0	51%	0.5079
1DV6_U10_M_1008	29%	28%	0.178	0.907	1.91	1.12	9	4	0	0	60%	0.6032
1DV6_U10_R_2009	10%	25%	0.229	0.859	2.02	1.22	3	2	2	0	29%	0.2857
1DV6_U10_L_1009	5%	27%	0.304	0.76	1.77	1.3	9	6	2	0	70%	0.6984
2BOZ_U10_M_1313	59%	23%	0.119	0.945	1.92	1.46	4	10	2	0	76%	0.7619
3ZUM_U10_M_1308	58%	9%	0.116	0.939	2.76	1.89	13	13	0	0	76%	0.7619
3ZUW_U10_M_1313	58%	10%	0.115	0.937	2.69	1.87	12	13	1	0	76%	0.7619
2GNU_U10_M_1305	55%	10%	0.111	0.931	2.57	1.9	11	16	1	0	71%	0.7143
2UWU_U10_M_1313	53%	12%	0.118	0.921	2.62	1.62	11	11	0	0	76%	0.7619
1K6N_U10_M_503	52%	18%	0.149	0.95	2.45	1.3	21	7	5	0	76%	0.7619

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.